logo

For the Inventor, By the Inventor

Clwyd, United Kingdom

Ronald S Gardner

USPTO Granted Patents = 13

Average Co-Inventor Count = 5.0

ph-index = 13

Forward Citations = 450(Granted Patents)


Location History:

  • Clwyd, GB (1998 - 2001)
  • Shotton, GB (1998 - 2001)

Company Filing History:

goldMedal13 out of 3,687 
 
Bristol-Myers Squibb Compnay
 patents

Years Active: 1998-2001

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6268483 - Compositions useful as fibrin sealants (2001-07-31),
2. 6262236 - Fibrin sealant compositions and methods for utilizing same (2001-07-17),
3. 6077507 - Method of making a composition comprising a fibrin monomer (2000-06-20),
4. 6048966 - Fibrin sealant compositions and methods for utilizing same (2000-04-11),
5. 5962420 - Fibrin sealant compositions and methods for utilizing same (1999-10-05),
6. 5962026 - Solid compositions of fibrin monomer (1999-10-05),
7. 5804428 - Fibrin sealant compositions and methods for utilizing same (1998-09-08),
8. 5773418 - Fibrin sealant compositions and methods for utilizing same (1998-06-30),
9. 5770194 - Fibrin sealant compositions and methods for utilizing same (1998-06-23),
10. 5763411 - Nondynamic fibrin monomer on bandages, sutures, prostheses and dressings (1998-06-09),
11. 5763410 - Kit for preparing a fibrin sealant (1998-06-09),
12. 5750657 - Methods and compositions using fibrin monomer to make a fibrin sealant (1998-05-12),
13. 5739288 - Fibrin sealant compositions (1998-04-14),

Title: Inventor Spotlight: Ronald S. Gardner

Introduction: Ronald S. Gardner, a distinguished inventor based in Clwyd, GB, has made significant contributions to the field of medical innovations. With a total of 13 patents to his name, Gardner's work focuses primarily on the development of advanced fibrin sealant compositions, which have vital applications in medical procedures.

Latest Patents: Among his latest patents, Ronald S. Gardner has pioneered compositions that are beneficial as fibrin sealants. These novel fibrin monomer compositions are formulated as solutions incorporating coharvested components such as prothrombin and Factor XIII. Notably, these compositions are designed to be autologous to the patient, enhancing their effectiveness. Other essential components may include coharvested plasminogen, Factor X, antithrombin III, and fibronectin. His inventions also encompass methods for utilizing fibrin sealants, specifically through the use of fibrin monomer or noncrosslinked fibrin as key components.

Career Highlights: Ronald S. Gardner is currently affiliated with Bristol-Myers Squibb Company, where he continues to advance the field of medical innovations. His career is marked by a dedication to improving medical outcomes through innovative solutions that leverage the body's natural healing processes.

Collaborations: Throughout his career, Gardner has worked alongside esteemed colleagues, including John E. Fairbrother and Derek A. Hollingsbee. These collaborations have further enriched his work, fostering a spirit of innovation within their projects.

Conclusion: Ronald S. Gardner's contributions to the field of fibrin sealants exemplify the pivotal role of inventors in shaping advancements in healthcare. With his impressive portfolio of patents, Gardner continues to inspire and innovate, providing valuable solutions that enhance medical treatments worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…